![Le Le Zhang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Le Le Zhang
Founder at
CUTIA THERAPEUTICS
Net worth: 7 M $ as of 2026-05-30
Profile
Le Le Zhang is the founder of Cutia Therapeutics, founded in 2019, holding the title of Chief Executive Officer & Executive Director since 2022.
The current job is General Manager & Director at Cutia Therapeutics (Shanghai) Co., Ltd. Education history includes a graduate degree from Shanghai Institute of Pharmaceutical Industry in 2005 and an undergraduate degree from Shenyang Pharmaceutical University in 2000.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CUTIA THERAPEUTICS 4.11% | 2025-11-02 | 15,007,236 ( 4.11% ) | 7 M $ | 2026-05-30 |
Le Le Zhang active positions
| Companies | Position | Start |
|---|---|---|
| CUTIA THERAPEUTICS | Founder | 2019-05-14 |
Cutia Therapeutics (Shanghai) Co., Ltd.
 Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics to severe facial acne vulgaris | Chief Executive Officer | - |
Training of Le Le Zhang
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Shanghai Institute of Pharmaceutical Industry
 Shanghai Institute of Pharmaceutical Industry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenyang Pharmaceutical University
 Shenyang Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cutia Therapeutics (Shanghai) Co., Ltd.
Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics to severe facial acne vulgaris | Health Technology |
Cutia Therapeutics
 Cutia Therapeutics Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing and marketing of dermatology based biopharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Le Le Zhang
